Piperazincitrat
Piperazincitrat
Authorised
- Piperazine citrate
Product identification
Medicine name:
Piperazincitrat
Active substance:
- Piperazine citrate
Target species:
-
Chicken
-
Homing pigeon
-
Horse
-
Pig
Route of administration:
-
In drinking water use
Product details
Active substance and strength:
-
Piperazine citrate1000.00/milligram(s)1.00gram(s)
Pharmaceutical form:
-
Powder for use in drinking water
Withdrawal period by route of administration:
-
In drinking water use
-
Chicken
-
Egg5day
-
Meat and offal2day
-
-
Horse
-
Meat and offalno withdrawal periodDie Anwendung bei Pferden, die der Lebensmittelgewinnung dienen, ist im Falle eines Therapienotstandes gemäß § 56a Abs. 2 AMG zulässig. In diesem Fall sind die Wartezeiten gemäß § 12a TÄHAV einzuhalten.
-
Milkno withdrawal periodDie Anwendung bei Pferden, die der Lebensmittelgewinnung dienen, ist im Falle eines Therapienotstandes gemäß § 56a Abs. 2 AMG zulässig. In diesem Fall sind die Wartezeiten gemäß § 12a TÄHAV einzuhalten.
-
-
Pig
-
Meat and offal4day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP52AH
- QP52AH01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Germany
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
- Bela-Pharm GmbH & Co. KG
Marketing authorisation date:
Manufacturing sites for batch release:
- Bela-Pharm GmbH & Co. KG
Responsible authority:
- Federal Office Of Consumer Protection And Food Safety
Authorisation number:
- 6933298.00.00
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
German (PDF)
Published on: 6/09/2024
